Culture medium for endometrial organs and culture method thereof
By providing a specific composition of endometrial organoid culture medium and its culture method, the problem that the prior art cannot simulate the progress of adenomyosis disease and endometrial organoid differentiation is solved, and the dry multidirectional differentiation of organoids is achieved , revealing the pathogenesis of adenomyosis and endometriosis.
Patent Information
- Application Number
- CN202411205912.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-30
- Publication Date
- 2024-11-26
AI Technical Summary
The prior art cannot effectively simulate the progression of adenomyosis in humans, cannot understand the overall picture of endometrial lesions, and cannot achieve dry multidirectional differentiation of endometrial organoids.
Provide a culture medium for endometrial organoids and its cultivation method, including two compositions: medium A and medium B, to achieve dry multidirectional differentiation of organoids through specific components and steps, specifically including DEME/F12 , serum substitute, double antibody, SB202190, N2, B27, N-Acetyl-L-cysteine, Glutamax, Recombinant human EGF, Recombinant human Noggin, Recombinant human FGF-10, ALK-4, -5, -7 inhibitor, A83 -01, a combination of components such as Recombinant human Rspondin-1 and estradiol, combined with specific cell treatment and culture steps.
The stem multidirectional differentiation of endometrial organoids has been achieved, which can understand the pathogenesis of adenomyosis and endometriosis, and reveal the differentiation potential and direction of endometrial stem cells.
Smart Images

Figure CN119020262A_ABST
Abstract
Description
Technical Field
[0002] The present invention relates to the field of biotechnology, and in particular to a culture medium for endometrial organoids and a culture method thereof. Background Art
[0003] In the past, due to the inability to conduct experiments and research directly on humans, theories about organ development and function were mostly based on speculation, and were subsequently widely used in the field of medical research, greatly promoting human understanding of physiological mechanisms and disease mechanisms. Despite this, the essential differences between humans and other animals in gene sequence and physiological structure have led to the fact that animal models are still unable to effectively simulate the real situation of the human body in many cases. Compared with 2D cell lines, organoids can better restore cell differentiation, cell movement, and complex interactions between cells and cells, and cells and extracellular matrix in the human body, and maintain the original phenotype and function of cells without considering cell passage. Compared with animal models, the composition and structure of organoids are more similar to those of real human organs, and can more realistically reproduce the development trajectory of human organs and the process of disease generation and development. It is currently the most promising alternative to animal testing.
[0004] Adenomyosis is a common gynecological myopathy, the main feature of which is the ectopic growth of endometrial tissue, which invades the uterine smooth muscle layer, leading to clinical symptoms such as pain, menstrual abnormalities, and infertility. Therefore, studying the physiological and pathological processes of the endometrium in adenomyosis is crucial for understanding and treating these gynecological diseases. Although a lot of research on endometrial organoids has been carried out and the culture of endometrial organoids has gradually matured, almost most of the endometrial organoid culture techniques are one-step methods, that is, endometrial organoids are directly cultivated using organoid culture medium. However, this approach cannot achieve the gradual deduction of the progression of adenomyosis, and cannot understand the full picture of the endometrial lesion process of adenomyosis. Summary of the invention
[0005] The present invention aims to at least partially overcome the above-mentioned technical problems and / or other potential problems existing in the prior art: to provide a culture medium and a culture method for endometrial organoids that can achieve multidirectional stem cell differentiation of endometrial organoids.
[0006] The technical solution of the present invention is as follows: a culture medium for endometrial organoids, comprising a culture medium A and a culture medium B, wherein the culture medium A comprises the following components: DEME / F12 (phenol red free), Serum replacement, Double antibody (100X), SB202190, Y-27632; The culture medium B comprises the following components: DEME / F12 (phenol red free), N2 (100X), B27 (50X), Double antibody (100X), N-Acetyl-L-cysteine, Glutamax (100X), Recombinant human EGF, Recombinant human Noggin, Recombinant human FGF-10, ALK-4, -5, -7 inhibitor, A83-01, Recombinant human Rspondin-1, Nicotinamide, Estradiol.
[0007] The present invention also provides a method for culturing endometrial organoids using the above culture medium, comprising the following steps: 1) Obtain fresh uterine endometrial tissue, cut it into small pieces with scissors, place it in collagenase IV digestion solution, and digest it in a shaking incubator at 37°C. The appearance of scattered glandular tissue in the digestion solution is regarded as a signal to stop digestion; 2) After digestion, add DEME / F12 (phenol red-free) medium containing 0.5% FBS (fetal bovine serum) in the same volume as the digestion solution and gently blow to stop digestion; after blowing, let the digestion solution containing tissues stand and settle, take the supernatant and transfer it to a 100μm cell sieve for filtration. The filtrate is a single cell suspension, while the dry glandular tissue is retained on the 100μm filter; 3) Invert the 100 μm filter, collect the dry tissue on the filter into a centrifuge tube using PBS, centrifuge at 4°C, discard the supernatant, and collect the precipitate; 4) Blow up the precipitate with serum-free DEME / F12 (phenol red-free) medium, centrifuge again and discard the supernatant, add serum-free DEME / F12 (phenol red-free) medium to resuspend the precipitate again, and place the centrifuge tube on ice; 5) Melt BME (Cultrex Reduced Growth Factor BME, Type 2) on ice and add BME to the centrifuge tube in step 4) at a volume ratio of 2:8. Mix by pipetting and keep the centrifuge tube on ice. Add 25 μl of BME containing stem cells to a 48-well low-adhesion cell culture plate (NEST) per well and place in a 37°C, 5% CO2 cell culture incubator for 15-20 minutes. 6) After BME solidifies into cell spheres, add culture medium A to each well and culture in a 37°C, 5% CO2 cell culture incubator. Replace culture medium A every day for the next 4 days. 7) After 5 days, the endometrial organoids grew in number and all had differentiated functions; 8) Add endometrial organoids to medium B starting on day 6 and change the medium every 2-3 days; 9) On days 10-12, mince the endometrial organoids and transfer them together with the culture medium to a 15 ml centrifuge tube in an ice bath. Pipette 30 times and centrifuge at 1500 rpm for 3 min at 4°C. Repeat with PBS once. Finally, re-inoculate with serum-free DEME / F12 (phenol red-free) culture medium according to steps 5) and 6), or directly freeze using serum-free freezing medium.
[0008] The beneficial effects of the present invention are as follows: the culture medium of the endometrial organoids of the present invention and the culture method thereof can achieve multidirectional differentiation of organoid stemness, which can not only understand the pathogenesis of adenomyosis and endometriosis, but also understand the differentiation potential and direction of endometrial stem cells. BRIEF DESCRIPTION OF THE DRAWINGS
[0009] Figure 1 This is a diagram showing the identification results of stemness-related protein markers in the first 5 days of culture of adenomyosis endometrial organoids in the example.
[0010] Figure 2 This is a diagram of the cell morphology of the adenomyosis endometrium in the first 5 days after the organoids undergo adipogenic and osteogenic differentiation induction in the example.
[0011] Figure 3 This is a morphological diagram of osteogenic differentiation cells in endometrial organoids in the first 5 days of the embodiment.
[0012] Figure 4 This is a morphological picture of the adenomyosis endometrial organoids in the example after being fully induced for 10 days and then passaged to the P2 generation.
[0013] Figure 5 This is the HE staining image of the P2 generation 10 days after the adenomyosis endometrial organoids were fully induced in the example.
[0014] Figure 6 This is a diagram showing the expression of CK protein (keratin) in adenomyosis endometrial organoids cultured on day 12 by immunofluorescence in the example. DETAILED DESCRIPTION
[0015] The present invention is further described in detail below with specific examples, but the present invention is not limited to the following specific examples. Example
[0016] This embodiment provides a specific culture medium for endometrial organoids, including culture medium A and culture medium B: Endometrial Organoid Medium A Recipe (50 ml): 1. DEME / F12 (without phenol red): 44.4 ml; 2. Serum replacement: 5ml; 3. Double antibody (100X): 0.5ml; 4. SB202190 (initial concentration: 10 mM, final concentration: 10 μM): 0.05 ml; 5. Y-27632 (initial concentration: 10 mM, final concentration: 10 μM): 0.05 ml; Endometrial Organoid Medium B Recipe (40 ml): 1. DEME / F12 (without phenol red) 37.74ml; 2. N2 (100X): 400 μl; 3. B27 (50X): 800 μl; 4. Double antibody (100X): 0.5ml; 5. N-Acetyl-L-cysteine (initial concentration: 1 M, final concentration: 1.25 mM): 50 μl; 6. Glutamax (100X): 400μl; 7. Recombinant human EGF (initial concentration: 500 μg / ml, final concentration: 50 ng / ml): 8 μl; 8. Recombinant human Noggin (initial concentration: 50 μg / ml, final concentration: 100 ng / ml): 80 μl; 9. Recombinant human FGF-10 (initial concentration: 50 μg / ml, final concentration: 100 ng / ml): 80 μl; 10. ALK-4, -5, -7 inhibitor, A83-01 (Manufacturer: STEMCELL, Catalog: 72022) CAS number: 909910-43-6, initial concentration: 10 mM, final concentration: 500 nM): 2 μl; 11. Recombinant human Rspondin-1 (initial concentration: 50 μg / ml, final concentration: 500 ng / ml): 400 μl; 12. Nicotinamide (initial concentration: 10 μM, final concentration: 10 nM): 40 μl; 13. Estradiol (initial concentration: 10 μM, final concentration: 10 nM): 40 μl; Endometrial organoid digestion and first 5 days of culture 1) Obtain fresh uterine endometrial tissue and cut the tissue into 1 cm pieces with scissors. 3 Small pieces were placed in collagenase IV (1 mg / ml) digestion solution and digested in a shaking incubator at 37°C. After 20 minutes of digestion, the digestion solution was aspirated, smears were made, and the presence of scattered glandular tissue was observed under an optical microscope. The presence of scattered glandular tissue in the digestion solution was regarded as a signal to stop digestion. The whole process took about 40 minutes.
[0017] 2) After digestion, add an equal volume of DEME / F12 (phenol red-free) medium containing 0.5% FBS and gently pipette 30 times to stop digestion. After pipetting, let the digestion solution containing tissue stand for 1 minute and 30 seconds to allow large pieces of undigested tissue to sink to the bottom of the tube. Use a 1ml pipette to carefully transfer the supernatant to a 100μm cell sieve for filtration. The filtrate is a single cell suspension, while the dry glandular tissue is retained on the 100μm filter.
[0018] 3) Invert the 100 μm filter and collect the dry tissue on the filter into a 50 ml centrifuge tube using PBS. Centrifuge at 1500 rpm, 3 min, 4°C, discard the supernatant, and collect the precipitate.
[0019] 4) Blow up the precipitate with serum-free DEME / F12 (phenol red-free) medium and centrifuge again under the same centrifugation conditions as above. After centrifugation, discard the supernatant, add 40μl serum-free DEME / F12 (phenol red-free) medium to resuspend the precipitate again, and place the centrifuge tube on ice.
[0020] 5) Melt BME (Cultrex Reduced Growth Factor BME, Type 2) on ice, and add 160μl of BME to the centrifuge tube in step 4) at a volume ratio of 2:8, pipette and mix well, and keep the centrifuge tube on ice throughout the operation. Add 25μl of BME containing stem cells to a 48-well low-adhesion cell culture plate (NEST) at a volume of 25μl per well, and place it in a 37℃, 5% CO2 cell culture incubator for 20 minutes; 6) After BME solidifies into cell spheres, add 150 μl of culture medium A to each well and culture in a 37°C, 5% CO2 cell culture incubator. Replace culture medium A every day for the next 4 days. 7) After 5 days, the endometrial organoids grew in number and all had differentiated functions; Endometrial organoid differentiation and passaging 1) Add 150 μl of endometrial organoid culture medium B starting on day 6 of the organoid culture. Change the culture medium every 3 days and perform subculturing on day 12.
[0021] 2) On the day of subculturing, place the 15 ml centrifuge tube on ice, crush the organoid gel with a yellow pipette tip, and aspirate it together with the culture medium into the 15 ml centrifuge tube in an ice bath. Pipette 30 times, centrifuge at 1500 rpm, 3 min, 4°C, repeat with PBS once, and repeat with serum-free DEME / F12 (phenol red-free) culture medium for the third time. Then re-inoculate according to steps 5-6 of the endometrial organoid digestion and the first 5 days of culture protocol, or directly freeze using serum-free freezing medium.
[0022] Endometrial organoid cryosection and fluorescence identification When the endometrial organoids reach P2, frozen sections and fluorescence identification can be performed as follows: 1) After removing the culture medium, add organoid fixative (4% PFA + 0.5% GA) and fix at room temperature for 1 hour. After removing the fixative, wash with PBS twice, 3 minutes each time.
[0023] 2) Prepare 25% sucrose solution to dehydrate the organoids. Gently add MBE gel and move into the sucrose water. Place at 4°C. After 2 days, MBE sinks to the bottom of the tube, indicating that dehydration is complete.
[0024] 3) The MBE containing the organoids was removed from the sucrose water and frozen into sections with a thickness of 10 μm. After sectioning, HE and immunofluorescence staining were performed for identification.
[0025] 4) Fluorescence identification: Anti-PanCK antibody was used to perform immunofluorescence detection of endometrial organoids, and the steps were the same as general tissue immunofluorescence steps.
[0026] like Figure 1 As shown, the stemness-related protein markers were identified in the first 5 days of culture of adenomyosis endometrial organoids. The endometrial stem organoid cells expressed CD44 and CD105 in the first 5 days, indicating that the endometrial organoids have stemness at this stage.
[0027] like Figure 2-3As shown in the figure, the adenomyosis endometrium was induced to differentiate into adipogenesis and osteoblasts 5 days before induction. The results showed that oil red O staining showed lipid droplet reaction one week after adipogenesis induction. At the same time, the morphology of the organoids changed one week after osteogenic induction, and dense bone components appeared, indicating that the endometrial organoids have the function of differentiating into osteoblasts and lipid cells.
[0028] like Figure 4-5 As shown, 10 days after the adenomyosis endometrial organoids were fully induced, they were passaged to the P2 generation and HE staining was performed. The results showed that the cultured organoids presented dark purple glands, indicating that the endometrial organoids were finally induced to differentiate into mature endometrial tissue.
[0029] like Figure 6 As shown, 10 days after the adenomyosis endometrial organoids were fully induced, they were passaged to the P2 generation and subjected to Pan-CK fluorescent staining. The glandular epithelial cells of the organoids were identified by immunofluorescence. The results showed that the adenomyosis endometrial organoids on the 12th day of culture expressed glandular epithelial cell keratin, indicating that the endometrial organoids were finally induced to differentiate into mature endometrial tissue.
[0030] The above are only examples of the features of the present invention and do not constitute any limitation on the protection scope of the present invention. Any technical solution formed by equivalent exchange or equivalent replacement falls within the protection scope of the present invention.
Claims
1. A culture medium for endometrial organoids, characterized in that It comprises culture medium A and culture medium B, wherein the culture medium A comprises the following components: DEME / F12 (phenol red free), Serum replacement, Double antibody (100X), SB202190, Y-27632; The culture medium B comprises the following components: DEME / F12 (phenol red free), N2 (100X), B27 (50X), Double antibody (100X), N-Acetyl-L-cysteine, Glutamax (100X), Recombinant human EGF, Recombinant human Noggin, Recombinant human FGF-10, ALK-4, -5, -7 inhibitor, A83-01, Recombinant human Rspondin-1, Nicotinamide, Estradiol.
2. A method for culturing endometrial organoids using the culture medium of claim 1, characterized in that: The following steps are involved: 1) Obtain fresh uterine endometrial tissue, cut it into small pieces with scissors, place it in collagenase IV digestion solution, and digest it in a shaking incubator at 37°C. The appearance of scattered glandular tissue in the digestion solution is regarded as a signal to stop digestion; 2) After digestion, add an equal volume of DEME / F12 (phenol red-free) medium containing 0.5% FBS (fetal bovine serum) to the digestion solution and gently blow to stop digestion; after blowing, let the digestion solution containing tissues stand to settle, take the supernatant and transfer it to a 100μm cell sieve for filtration. The filtrate is a single cell suspension, while the dry glandular tissue is retained on the 100μm filter; 3) Invert the 100 μm filter, collect the dry tissue on the filter into a centrifuge tube using PBS, centrifuge at 4°C, discard the supernatant, and collect the precipitate; 4) Blow up the precipitate with serum-free DEME / F12 (phenol red-free) medium, centrifuge again and discard the supernatant, add serum-free DEME / F12 (phenol red-free) medium to resuspend the precipitate again, and place the centrifuge tube on ice; 5) Melt BME (Cultrex Reduced Growth Factor BME, Type 2) on ice and add BME to the centrifuge tube in step 4) at a volume ratio of 2:
8. Mix by pipetting. Keep the centrifuge tube on ice during the whole process. Add BME containing stem cells to a low attachment cell culture plate (NEST) and place it in a 37°C, 5% CO2 cell culture incubator for 15-20 minutes. 6) After BME solidifies into cell spheres, add culture medium A to each well and culture in a 37°C, 5% CO2 cell culture incubator. Replace culture medium A every day for the next 4 days. 7) After 5 days, the endometrial organoids grew in number and all had differentiated functions; 8) Add endometrial organoids to medium B starting on day 6 and change the medium every 2-3 days; 9) On days 10-12, mince the endometrial organoids and transfer them to an ice-cold centrifuge tube along with the culture medium. Pipette 30 times and centrifuge at 4°C. Finally, re-inoculate with serum-free DEME / F12 (phenol red-free) culture medium according to steps 5) and 6), or directly freeze using serum-free freezing medium.
Citation Information
Cited By
Endometrial organoid culture method
CN120400031A
